Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...